Ranolazine 1000 mg (Extended Release) Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Ranolazine 1000 mg (Extended Release) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Late sodium-current inhibitor (anti-anginal)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Ranolazine 1000 mg (Extended Release) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Ranolazine 1000 mg (Extended Release) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Ranolazine 1000 mg (Extended Release) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Ranolazine 1000 mg (Extended Release) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Chronic stable angina (refractory)
- Add-on in patients with HR/BP already optimised
- Angina in patients intolerant to beta-blockers/CCBs
Mechanism of Action
Ranolazine selectively inhibits the late sodium current in cardiomyocytes. Reduction of intracellular sodium reduces calcium overload during diastole, decreasing ventricular wall tension and improving myocardial perfusion. Unlike other anti-anginals, it does not significantly reduce HR or BP.
Dosage & Administration
- Adults: 500–1000 mg twice daily
- Take with or without food
- Swallow whole — do not crush or chew
- Avoid grapefruit juice
Side Effects
- Dizziness
- Constipation
- Nausea
- QT prolongation (dose-related)
- Headache
Contraindications
- Severe hepatic impairment
- Concurrent strong CYP3A4 inhibitors
- Pre-existing QT prolongation
- Pregnancy and breastfeeding
Storage
Store below 25°C.
PCD Pharma Franchise for Ranolazine 1000 mg (Extended Release) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Ranolazine 1000 mg (Extended Release) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Ranolazine 1000 mg (Extended Release) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Ranolazine 1000 mg (Extended Release) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Ranolazine 1000 mg (Extended Release) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Ranolazine 1000 mg (Extended Release) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Ranolazine 1000 mg (Extended Release) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Ranolazine 1000 mg (Extended Release) Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Ranolazine 1000 mg (Extended Release) Tablet?
MRPs range from ₹2490 to ₹2490 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Ranolazine 1000 mg (Extended Release) Tablet?